Stephan Debotton Selected Research

Mitoxantrone (Novantrone)

1/2004

A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Debotton Research Topics

Disease

2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2006 - 01/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2006
1	Leukopenia 01/2004
1	Neutropenia 01/2004
1	Thrombocytopenia (Thrombopenia) 01/2004

Drug/Important Bio-Agent (IBA)

1	fludarabineIBA 01/2004
1	NucleotidesIBA 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004
1	Arabinofuranosylcytosine TriphosphateIBA 01/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2004

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 03/2006 - 01/2004
2	Stem Cell Transplantation 03/2006 - 01/2004
1	Combination Drug Therapy (Combination Chemotherapy) 01/2004
1	FAM protocol 01/2004